CAS No.56796-39-5,Cefmetazole sodium Suppliers,MSDS download

Products Categories

Pharmaceutical (86)
Organic Chemicals (19)
Others (3)
Reagent (2)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	56796-39-5
Name:	Cefmetazole sodium
Article Data:	3

Formula:	C₁₅H₁₆N₇NaO₅S₃
Molecular Weight:	493.524
Synonyms:	5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R,7S)- (9CI);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt, (6R-cis)-;CS-1170 sodium salt;Cefmetazole sodium;Cefmetazole-Na;Cefmetazon;Cefmetazone;Metafar;Sodium cefmetazole;Zefazone;
EINECS:	260-384-2
Density:	1.75 g/cm3
Solubility:	Soluble in water
Appearance:	White solid
Hazard Symbols:	Xi
Risk Codes:	36/37/38-42/43
Safety:	26-36
PSA:	242.06000
LogP:	-1.73422

Total:85 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 56796-39-5

Chemistry

IUPAC Name: Sodium (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Systematic of Cefmetazole sodium (CAS NO.56796-39-5): Cefmetazole sodium [USAN:JAN] ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-cis)- ; CMZ sodium ; CS 1170 sodium ; Cefmetazon ; SKF 83088 sodium ; Sodium (6R,7S)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate ; U 72791A ; UNII-37Y9VR4W7A ; Zefazone ; Zefazone in plastic container ; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((((cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, sodium salt, (6R-cis)-
CAS NO: 56796-39-5
Classification Code: Antibacterial ; Drug / Therapeutic Agent ; Reproductive Effect
Molecular Formula of Cefmetazole sodium (CAS NO.56796-39-5): C₁₅H₁₆N₇NaO₅S₃
Molecular Weight: 493.5162
Molecular Structure:

ProductCategories: Chiral Reagents ; Heterocycles ; Intermediates & Fine Chemicals ; Pharmaceuticals ; Sulfur & Selenium Compounds ; A - KAntibiotics ; Antibacterial ; Antibiotics A to ; Antibiotics A-FAntibiotics ; Chemical Structure Class ; Interferes with Cell Wall SynthesisAntibiotics ; Mechanism of Action ; Penicillins and Cephalosporins (beta-Lactams) ; Spectrum of Activity
H bond acceptors: 12
H bond donors: 2
Freely Rotating Bonds: 9
Polar Surface Area of Cefmetazole sodium (CAS NO.56796-39-5): 230.44 Å²

Uses

Cefmetazole sodium (CAS NO.56796-39-5) is used as antibacterial

Toxicity Data With Reference

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	intravenous	> 1600mg/kg (1600mg/kg)		Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 22, Pg. 123, 1980.
mouse	LD50	intraperitoneal	10233mg/kg (10233mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978.
mouse	LD50	intravenous	8690mg/kg (8690mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978.
mouse	LD50	oral	3228mg/kg (3228mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Journal of Pharmacobio-Dynamics. Vol. 8, Pg. 633, 1985.
mouse	LD50	subcutaneous	12190mg/kg (12190mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978.
rat	LD50	intraperitoneal	> 7500mg/kg (7500mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978.
rat	LD50	intravenous	> 5gm/kg (5000mg/kg)		Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978.
rat	LD50	oral	3204mg/kg (3204mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Journal of Pharmacobio-Dynamics. Vol. 8, Pg. 633, 1985.
rat	LD50	subcutaneous	> 12500mg/kg (12500mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES	Sankyo Kenkyusho Nempo. Annual Report of Sankyo Research Laboratories. Vol. 30, Pg. 112, 1978.

Safety Profile

Hazard Codes: Harmful Xn, Irritant Xi
Risk Statements: 36/37/38-42/43
R36/37/38: Irritating to eyes, respiratory system and skin.
R42/43: May cause sensitization by inhalation and skin contact.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36: Wear suitable protective clothing.
WGK Germany: 2
RTECS: XI0372200